Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.

We have shown previously (W. Löscher et al., Cancer Lett., 71: 75-81, 1993; M. Mevissen et al., Carcinogenesis (Lond.), 17: 903-910, 1996) that 50-Hz magnetic fields (MFs) of low [50 or 100 microTesla (T)] flux density enhance mammary gland tumor development and growth in the 7,12-dimethylbenz[a]anthracene (DMBA) model of breast cancer in female Sprague Dawley rats. In these previous experiments, groups of rats were given 20 mg of DMBA (four weekly gavage doses of 5 mg each) and were MF- or sham-exposed for 13 weeks. The objective of the present study was to examine whether the use of a lower dose of DMBA (10 instead of 20 mg per rat), MF exposure of the rats before DMBA injection, and the increase of the MF exposure period after DMBA application to 26 weeks enhance the effect of MF on tumor development and growth. A group 99 rats was exposed to a homogeneous, horizontally polarized 100-microT MF of 50-Hz for 24 h/day for 7 days/week; another group of 99 rats was sham-exposed under the same environmental conditions as the MF-exposed rats. The exposure chambers were identical for MF-exposed and sham-exposed animals. The age of the rats was 45-49 days at the onset of exposure; duration of MF or sham exposure was 27 weeks. DMBA was administered p.o. at a dose of 10 mg/rat after 1 week of MF or sham exposure. The animals were palpated once weekly from week 6 onwards to assess the development of mammary tumors. At the end of the exposure period, the animals were killed for the determination of number and volume and histological verification of mammary tumors. All of the recordings were done in a blinded fashion; i.e., the investigators were not aware which animals were MF- or sham-exposed. Mammary tumor development and growth was significantly enhanced by MF exposure, the most marked effect on tumor incidence (190% above sham control) being observed 13 weeks after DMBA administration. At the time of necropsy, i.e., 26 weeks after DMBA administration, the incidence of histologically verified mammary tumors was 50.5% in controls and 64.7% in MF-exposed rats, the difference being statistically significant. More marked intergroup differences were recorded when tumor incidence was separately evaluated for each of the six mammary complexes, the most pronounced MF effect on tumor incidence being seen in the cranial thoracic complex. The data substantiate that, at least under the experimental conditions used in our laboratory, 50-Hz, 100-microT MF exposure significantly facilitates the development and growth of mammary tumors in the DMBA rat model of breast cancer.

[1]  M Kietzmann,et al.  In vivo exposure of rats to a weak alternating magnetic field increases ornithine decarboxylase activity in the mammary gland by a similar extent as the carcinogen DMBA. , 1995, Cancer letters.

[2]  J. J. Broerse,et al.  Differences in DMBA-induced mammary neoplastic responses in two lines of Sprague-Dawley rats. , 1984, European journal of cancer & clinical oncology.

[3]  N. Wertheimer,et al.  Re: Are electric or magnetic fields affecting mortality from breast cancer in women? , 1994, Journal of the National Cancer Institute.

[4]  L. E. Anderson,et al.  Electric power, pineal function, and the risk of breast cancer , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  B. Gusterson,et al.  Classification of Neoplastic and Nonneoplastic Lesions of the Rat Mammary Gland , 1989 .

[6]  R. Reiter.  A review of neuroendocrine and neurochemical changes associated with static and extremely low frequency electromagnetic field exposure , 1993, Integrative physiological and behavioral science : the official journal of the Pavlovian Society.

[7]  W. Löscher,et al.  Animal and cellular studies on carcinogenic effects of low frequency (50/60-Hz) magnetic fields. , 1998, Mutation research.

[8]  W. Löscher,et al.  Alterations in ornithine decarboxylase activity in the rat mammary gland after different periods of 50 Hz magnetic field exposure. , 1999, Bioelectromagnetics.

[9]  D S Beniashvili,et al.  Low-frequency electromagnetic radiation enhances the induction of rat mammary tumors by nitrosomethyl urea. , 1991, Cancer letters.

[10]  P. Riley.  THE MELATONIN HYPOTHESIS: BREAST CANCER AND USE OF ELECTRIC POWER , 1998 .

[11]  K. H. Mild,et al.  Mammary tumours in Sprague-Dawley rats after initiation with DMBA followed by exposure to 50 Hz electromagnetic fields in a promotional scheme. , 1998, Cancer letters.

[12]  J. Russo,et al.  Mammary gland neoplasia in long-term rodent studies. , 1996, Environmental health perspectives.

[13]  N. Wertheimer,et al.  Magnetic Field Exposure Related to Cancer Subtypes , 1987, Annals of the New York Academy of Sciences.

[14]  S Buntenkötter,et al.  Effects of magnetic fields on mammary tumor development induced by 7,12-dimethylbenz(a)anthracene in rats. , 1993, Bioelectromagnetics.

[15]  D A Savitz,et al.  Breast cancer mortality among female electrical workers in the United States. , 1994, Journal of the National Cancer Institute.

[16]  W. Lehmacher,et al.  Tumor promotion in a breast cancer model by exposure to a weak alternating magnetic field. , 1993, Cancer letters.

[17]  T B Wenzl,et al.  Occupational Exposure to 60‐Hertz Magnetic Fields and Risk of Breast Cancer in Women , 1996, Epidemiology.

[18]  S. Reuss,et al.  Magnetic field effects on the rat pineal gland: Role of retinal activation by light , 1986, Neuroscience Letters.

[19]  R. Stevens,et al.  Electric power use and breast cancer: a hypothesis. , 1987, American journal of epidemiology.

[20]  W. Löscher,et al.  Acceleration of mammary tumorigenesis by exposure of 7,12-dimethylbenz[a]anthracene-treated female rats in a 50-Hz, 100-microT magnetic field: replication study. , 1998, Journal of toxicology and environmental health. Part A.

[21]  G. Cornelissen,et al.  Chronobiologic response modifiers and breast cancer development: classical background and chronobiologic tasks remaining. , 1992, In vivo.

[22]  W. Löscher,et al.  Magnetic Fields and Breast Cancer: Experimental in Vivo Studies on the Melatonin Hypothesis , 1999 .

[23]  O. Torgersen.  Regional distribution of DMBA-induced mammary tumours in the rat. , 2009, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.

[24]  W. Löscher,et al.  Linear relationship between flux density and tumor co-promoting effect of prolonged magnetic field exposure in a breast cancer model. , 1995, Cancer letters.

[25]  M Feychting,et al.  Magnetic Fields and Breast Cancer in Swedish Adults Residing near High‐Voltage Power Lines , 1998, Epidemiology.

[26]  W. Löscher,et al.  A histopathological study on alterations in DMBA-induced mammary carcinogenesis in rats with 50 Hz, 100 muT magnetic field exposure. , 1995, Carcinogenesis.

[27]  International classification of rodent tumours. Part I--The rat. 6. Endocrine system. , 1994, IARC scientific publications.

[28]  A. E. Rogers.  Factors That Modulate Chemical Carcinogenesis in the Mammary Gland of the Female Rat , 1989 .

[29]  J. Russo,et al.  Pathogenesis of Mammary Carcinomas Induced in Rats by 7, 12-Dimethylbenz[a]anthracene , 1977 .

[30]  W. Löscher,et al.  Exposure of DMBA-treated female rats in a 50-Hz, 50 microTesla magnetic field: effects on mammary tumor growth, melatonin levels, and T lymphocyte activation. , 1996, Carcinogenesis.

[31]  D. Trichopoulos.  Are electric or magnetic fields affecting mortality from breast cancer in women , 1994 .

[32]  R. Liburdy,et al.  ELF magnetic fields, breast cancer, and melatonin: 60 Hz fields block melatonin's oncostatic action on ER+ breast cancer cell proliferation , 1993, Journal of pineal research.